Evidence map›Paper›PMID 39065757›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

Medicinal Orchids of Mexico: A Review.

Luis J Castillo-Pérez, Amauri Ponce-Hernández, Angel Josabad Alonso-Castro, Rodolfo Solano, Javier Fortanelli-Martínez, Luicita Lagunez-Rivera, Candy Carranza-Álvarez

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Phytochemical Compounds fromPlants (Basel, Switzerland) · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis J Castillo-PérezPrograma Multidisciplinario de Posgrado en Ciencias Ambientales, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.ORCID 0000-0002-7481-2402
Amauri Ponce-HernándezFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.
Angel Josabad Alonso-CastroDepartamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato 36050, Mexico.ORCID 0000-0003-2660-8156
Rodolfo SolanoLaboratorio de Extracción y Análisis de Productos Naturales Vegetales, Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, Unidad Oaxaca, Instituto Politécnico Nacional, Santa Cruz Xoxocotlán 71230, Mexico.ORCID 0000-0002-0355-5496
Javier Fortanelli-MartínezInstituto de Investigación de Zonas Desérticas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.ORCID 0000-0003-1958-7553
Luicita Lagunez-RiveraLaboratorio de Extracción y Análisis de Productos Naturales Vegetales, Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, Unidad Oaxaca, Instituto Politécnico Nacional, Santa Cruz Xoxocotlán 71230, Mexico.ORCID 0000-0001-9870-971X
Candy Carranza-ÁlvarezFacultad de Estudios Profesionales Zona Huasteca, Universidad Autónoma de San Luis Potosí, Ciudad Valles 79060, Mexico.

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías 269491/2016Consejo Nacional de Humanidades, Ciencias y Tecnologías CBF2023-2024-1888
6 · The paper itself

Abstract

Some species of the Orchidaceae family are used in Mexican traditional medicine. However, there are no current and critical compilations of the medicinal uses and pharmacological effects of the members of the Orchidaceae family. This review provides a current, critical, and comprehensive analysis of the traditional medicinal uses, pharmacological reports, and active compounds isolated from Mexican orchids. A total of 62 Mexican orchids with medicinal potential have been recorded, of which 14 have scientific evidence. The remaining 48 plant species have ethnomedicinal information but have not been validated with scientific studies. These orchids are distributed in 14 states of the Mexican Republic, mainly in the southern region of Mexico. The most common pharmacological activities reported are anti-inflammatory, vasorelaxant, antinociceptive, antioxidant, spasmolytic, antihypertensive, and hallucinogenic activities. It is necessary to increase the number of pharmacological, phytochemical, and toxicological studies with medicinal orchids from Mexico because there are scientific studies on only 22.5% of these species. In further studies, it will be possible to evaluate the pharmacological effects of Mexican orchids in clinical trials. In addition, the mechanisms of action by which plant extracts and their active compounds exert medicinal effects remain to be studied. Plant extracts from orchids and their active compounds show promising antinociceptive and spasmolytic effects, respectively.

Indexed as

ethnomedicineMexican orchidspharmacologytraditional medicine

Identifiers

PMID39065757
PMCPMC11279439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.